Safe Orthopaedics : 2015 Financial Calendar

Regulatory News:

SAFE ORTHOPAEDICS (Paris:SAFOR) (FR0012452746 – SAFOR), a company developing and marketing an innovative range of sterile implants with associated single-use surgical instruments, to achieve safer, optimized and lower-cost spinal surgery, announced today its financial reporting schedule for 2015.

Financial publications will be released after market close. This schedule is indicative and subject to change.

About Safe Orthopaedics

Founded in 2010, Safe Orthopaedics is a French medical technology company that develops and markets an innovative range of sterile implants and associated single-use surgical instruments, with the aim of facilitating safer, optimized and lower-cost spinal surgery. By avoiding the reuse of surgical instruments, Safe Orthopaedics reduces the risk of infection, avoids the cumbersome and unreliable logistics of instrument sterilization, and limits hospital costs. Protected by 17 patent families, the company’s CE-marked and FDA-approved SteriSpine^TM kits are already being marketed in 12 countries, in Europe and the United States. They are being rapidly adopted by surgeons throughout the world, with more than 1,000 procedures performed during the past 12 months. The company is based at Eragny-sur-Oise (France), and has 30 employees and a US subsidiary.

For more information, visit: www.SafeOrtho.com